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In humans, neurosecretory chromaffin cells control a number of important bodily
functions, including those related to stress response. Chromaffin cells appear as a
distinct cell type at the beginning of midgestation and are the main cellular source of
adrenalin and noradrenalin released into the blood stream. In mammals, two different
chromaffin organs emerge at a close distance to each other, the adrenal gland and
Zuckerkandl organ (ZO). These two structures are found in close proximity to the
kidneys and dorsal aorta, in a region where paraganglioma, pheochromocytoma and
neuroblastoma originate in the majority of clinical cases. Recent studies showed that
the chromaffin cells comprising the adrenal medulla are largely derived from nerve-
associated multipotent Schwann cell precursors (SCPs) arriving at the adrenal anlage
with the preganglionic nerve fibers, whereas the migratory neural crest cells provide
only minor contribution. However, the embryonic origin of the ZO, which differs from
the adrenal medulla in a number of aspects, has not been studied in detail. The
ZO is composed of chromaffin cells in direct contact with the dorsal aorta and the
intraperitoneal cavity and disappears through an autophagy-mediated mechanism after
birth. In contrast, the adrenal medulla remains throughout the entire life and furthermore,
is covered by the adrenal cortex. Using a combination of lineage tracing strategies with
nerve- and cell type-specific ablations, we reveal that the ZO is largely SCP-derived
and forms in synchrony with progressively increasing innervation. Moreover, the ZO
develops hand-in-hand with the adjacent sympathetic ganglia that coalesce around
the dorsal aorta. Finally, we were able to provide evidence for a SCP-contribution to
a small but significant proportion of sympathetic neurons of the posterior paraganglia.
Thus, this cellular source complements the neural crest, which acts as a main source
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of sympathetic neurons. Our discovery of a nerve-dependent origin of chromaffin cells
and some sympathoblasts may help to understand the origin of pheochromocytoma,
paraganglioma and neuroblastoma, all of which are currently thought to be derived from
the neural crest or committed sympathoadrenal precursors.
Keywords: Zuckerkandl organ, extra-adrenal chromaffin cells, posterior trunk sympathetic ganglia, para-aortic
sympathetic ganglia, catecholamines, Schwann cell precursors
INTRODUCTION
Chromaffin cells are the main cell type responsible for the
production and systemic release of circulating catecholamines.
These include adrenaline and noradrenaline and allow the body
to respond to stress induced by a variety of external stimuli. This
stress-response is orchestrated by the cholinergic preganglionic
neurons of the central nervous system, which directly control
catecholamine release by peripheral neurosecretory chromaffin
cells. Additionally, catecholamines are fundamental during
embryonic development, participating in normal cardiac
development, as well as in hypoxia-induced stress response
in utero (Kobayashi et al., 1995; Thomas et al., 1995; Zhou
et al., 1995; Rios et al., 1999; Portbury et al., 2003; Ream et al.,
2008).
Even though the most well-known hub of chromaffin cells
in mammals is the medulla of the adrenal gland, an additional
chromaffin organ can be found next to the dorsal aorta, around
the mid-level of the kidneys and in a close association with
numerous sympathetic ganglia. This chromaffin organ, known as
Zuckerkandl organ (ZO), is the largest extra-adrenal chromaffin
body in mammals (Coupland, 1965; Böck, 1982; Zuckerkandl,
1901; Kohn, 1903). In rodents and other small mammals, ZO is a
transient embryonic organ, which reaches maximal cell numbers
just before or after birth and undergoes autophagy-mediated cell
death, which is initiated in early postnatal stages (Schober et al.,
2013). In humans, the ZO reaches the peak of its size around
the 3rd year of life and then slowly regresses, thus timing of ZO
disappearance is species-specific.
The connection between sympathetic neurons and chromaffin
cells is not only functional, which is the case in stress-
responses, but also has been rendered to be ontogenetic. Until
recently, research supported the conclusion that during early
embryogenesis multipotent neural crest cells migrate toward
the dorsal aorta in two waves, and in turn differentiate toward
either sympathetic or chromaffin cells as a response to secreted
factors from the aorta (Huber et al., 2009; Saito et al., 2012).
However, several studies have lately challenged that idea. Firstly,
the progenitors of the two systems seem to express discrete
markers even before they reach the area of the dorsal aorta
(Ernsberger et al., 2005; Chan et al., 2016). Furthermore, recent
studies proved that the two cell types are of different origin,
with the majority of adrenal chromaffin cells being derived late
from nerve-associated multipotent cells, also known as Schwann
cell precursors (SCPs), which use the axons of the preganglionic
neurons as a pathway to the sympathoadrenal (SA) anlage
(Furlan et al., 2017; Lumb et al., 2018). Additionally, single-cell
transcriptomic analysis of the developing SA progenitors allowed
sampling of both sympathoblasts and chromaffin cells during
early development and resulted in significant differences, as well
as similarities, in the molecular profiles and markers of the two
populations (Furlan et al., 2016, 2017).
The ZO, adrenal medulla and sympathetic ganglia are the
locations of paraganglioma (PGG) and pheochromocytoma
(PCC) (Huber et al., 2018). These tumors are very heterogeneous
and their origin is still not fully understood, although they
are considered to be composed of chromaffin cells (Lenders
et al., 2014). Given their similarities and common features,
it is becoming increasingly clear that it is important to
fully understand the normal development of chromaffin and
sympathetic structures found in the trunk.
In this study, using lineage tracing and genetic manipulations
during embryonic mouse development, we revealed that the
majority of chromaffin cells of the ZO are SCP-derived similarly
to those of the adrenal medulla, in contrast to the majority of the
cells of the sympathetic ganglia that are formed around the dorsal
aorta from the migratory neural crest cells. At the same time, we
identified a minor portion of SCP-derived sympathetic neurons
in the posterior trunk paraganglia.
These findings reveal the difference in origin of sympathetic
(mainly derived from neural crest cells) paraganglia and
chromaffin cells of ZO (mainly derived from SCPs). Taking into
account the role of innervation in the development of adrenal
medulla and ZO organ, the SCP-dependent alternative origin of a
minority of sympathetic neurons evokes a need to reconsider the
potential cellular origin of different subtypes of neuroblastoma,
PGG and PCC.
RESULTS
Chromaffin Cells of Zuckerkandl Organ
and Sympathoblasts of the
Mid-to-Lower-Trunk Arise From Different
Cellular Origins
Sympathetic neurons of the autonomic nervous system and
neuroendocrine chromaffin cells share many similarities, such as
expression of DBH and TH – enzymes involved in catecholamine
synthesis (Huber, 2006). However, a detailed study during the
development of the SA system showed that the two cell types can
be resolved by means of CART and TH expression. Specifically,
CART levels are high in newly formed sympathetic neurons,
while TH levels are low. In contrast, in chromaffin cells, TH levels
are high and CART is almost absent, even though a very small
portion of chromaffin cells is CART+ (Chan et al., 2016). When
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FIGURE 1 | The sympathetic ganglia at the level of the Zuckerkandl organ and the organ itself have distinct early-defined origin despite the intermingling anatomy.
(A) Dorsal view of whole-mount immunofluorescence (left panel) against the sympathetic marker CART, the chromaffin and sympathetic marker TH and NF200
(Continued)
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FIGURE 1 | Continued
showing the innervation on the trunk of an E15.5 wild type embryo and schematic (right panel) showing the sympathetic and chromaffin structures in relation to the
dorsal aorta. Note that the mesenteric (MG) and suprarenal ganglion (SRG), as well as the sympathetic chain (SC), are CART+, while the Zuckerkandl organ (ZO) is
composed mainly by TH+/CART- cells. Additionally note that the para-aortic ganglia (PAG) are the continuation of the sympathetic chain that extends along the
anteroposterior axis of the embryo trunk just at the dorsal view of the dorsal aorta, at the level of the ZO and MG. (B,C) Immunofluorescence on cryosections against
CART, RetTOM and TH on tamoxifen-injected (TAM-injected) embryos at E10.5 and E11.5 respectively shows that RetTOM specifically delineated the sympathetic
compartment when analyzed at E15.5, with clear tracing of the MG and PAG, while only few RetTOM+ cells can be seen in the ZO. Note the difference in CART
immunofluorescence levels in the MG and PAG. (D) Immunofluorescence on cryosections against ISL1, RetTOM and TH on TAM-injected embryos at E10.5 shows
RetTOM specific expression by the sympathetic ganglion (SG) and SRG when analyzed at E15.5, while almost no RetTOM+ cells can be seen in the adrenal medulla
(AM). (E) Ventral view of whole-mount immunofluorescence against CART, Ascl1TOM and TH on embryos with TAM injection at E11.5 and analyzed at E13.5 shows
tracing in the chromaffin cells of the ZO, while no tracing in the MG (shown by white arrowheads). Scale bar in (A–E) = 100 µm. A, anterior; P, posterior; AM, adrenal
medulla; MG, mesenteric ganglion; ZO, Zuckerkandl organ; DA, dorsal aorta; SC, sympathetic chain; SRG, suprarenal ganglion; AG, adrenal gland; PAG, para-aortic
ganglion; SG, sympathetic ganglion; ChCs, chromaffin cells; SNs, sympathetic neurons.
it comes to the Zuckerkandl organ (ZO) and adrenal medulla
(AM), the two chromaffin organs do not appear to have any
molecular differences, but only anatomical and morphological
discrepancies. As opposed to the chromaffin cells of the adrenal
medulla, which are clearly separated from the sympathetic
ganglia in their vicinity by the surrounding adrenal cortex,
chromaffin cells of ZO are immediately surrounded by numerous
sympathetic ganglia (Figures 1A,B). Additionally, whole mount
immunofluorescence at E15.5 shows that the posterior part of the
ZO is composed in a significant degree of CART+/TH+ cellular
populations, hinting to a potential composite nature (Figure 1A).
From the literature, it is clear that the adrenal primordium can
be identified as early as E11.5, but the first TH+ chromaffin cells
in the area can only be identified a day later (Huber et al., 2009;
Lumb et al., 2018). Thus, we chose to analyze the progenitors of
the sympathetic and chromaffin lineages at the level of the ZO at
E10.5 and E11.5.
During development, the receptor RET is expressed in a
dynamic way by sympathetic neurons and chromaffin cells and is
essential for the development of all sympathetic neurons, whereas
it is dispensable for the development of the chromaffin cells
of the adrenal medulla (Enomoto et al., 2001; Allmendinger
et al., 2003). To test RET involvement in the lineage separation
within the ZO and the adjacent sympathetic ganglia, we used the
inducible RetCreERT2;R26TOM reporter line (referred from now on
as RetTOM). By injecting tamoxifen (TAM) at E10.5 or E11.5 and
analyzing the ZO with the mesenteric/para-aortic sympathetic
ganglia around it, we found that the two components are of
different origin, with RetTOM+ cells traced from either E10.5 or
E11.5 giving rise only to the sympathetic mesenteric and para-
aortic ganglia and not chromaffin cells of the ZO (Figures 1B,C).
Thus, the lineages of sympathetic ganglia and chromaffin cells
at the level of the ZO are already separated at E10.5, similarly
to what was observed in the case of the sympathetic ganglia at
the vicinity of the adrenal gland and the chromaffin cells of the
adrenal medulla (Figure 1D) (Furlan et al., 2017). Additionally,
we observed that the sympathetic identity-specific marker CART
(Chan et al., 2016; Furlan et al., 2017) is expressed in lower
levels in the mesenteric ganglion in comparison to the para-
aortic ganglia in the vicinity of the ZO at E15.5 (Figures 1B,C,
insets). Higher levels of CART expression in sympathetic neurons
have been correlated with earlier developmental points, showing
the peak of expression at E12.5, while CART is expressed in
progressively lower levels at later stages (Chan et al., 2016).
This suggests that the mesenteric ganglia are generated earlier or
mature faster as compared to the para-aortic ganglia.
Another key gene that is important for the development of
both sympathetic neurons and the medullary chromaffin cells
is Ascl1 (Mash1) (Huber et al., 2002a,b). Additionally, Ascl1 is
a master regulator transcription factor with dynamic expression
during SA development, delineating only chromaffin cells when
lineage tracing is initiated after E11.5 (Furlan et al., 2017). Using
the inducible Ascl1CreERT2;R26TOM reporter line, we injected
TAM at E11.5. Analysis of Ascl1TOM+ embryos at E13.5 showed
that the ZO is derived from E11.5 Ascl1+ progenitors, while
the mesenteric and other paraganglia are not derived from the
Ascl1TOM+ lineage (Figure 1E), confirming the two separate
lineages of the sympathetic neurons and chromaffin cells at the
level of the ZO that we observed with the RetTOM+ tracing.
Thus, by means of the inducible expression of RetTOM+ and
Ascl1TOM+, we showed that even though the sympathetic ganglia
surrounding the ZO and the chromaffin cells of the ZO develop in
a tight spatial association with each other, they are derived from
different progenitors, as opposed to what was believed before.
Zuckerkandl Organ and a Newly
Identified Extra-Adrenal Chromaffin
Body Are Largely Generated From
Nerve-Derived SCPs
As mentioned above, cells of the Ret+ lineage traced from E10.5
and E11.5 delineated specifically the sympathetic mesenteric and
para-aortic ganglia and not the chromaffin cells of ZO, indicating
that the neuroendocrine chromaffin cells of the ZO are not
derived from Ret+ precursors. It has been previously established
that at E11.5 there are no more freely-migrating neural crest cells,
and that only nerve-associated SCPs can be found in the mouse
trunk (Furlan et al., 2017). Thus, given the absence of RetTOM+
cells traced from E10.5 and E11.5 in the chromaffin cells of the
ZO, we reasoned that the organ could be derived from nerve-
associated SCPs, similarly to the chromaffin cells of the adrenal
gland (Furlan et al., 2017).
To test this, we first used the Plp1CreERT2;R26YFP reporter
line (referred to from now on as Plp1YFP), a strain that
has been used in the past to trace peripheral glia (or
Schwann cells) during development and in adult mice
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FIGURE 2 | The chromaffin cells of the Zuckerkandl organ are grossly Schwann-cell-precursor-derived, as well as a small portion of the posterior trunk sympathetic
ganglia. (A) Side view of whole-mount immunofluorescence against Plp1YFP, TH and CART on an E12.5 embryo which received a single tamoxifen (TAM) injection at
E11.5, showing the sympathoadrenal (SA) primordium area. Note the big accumulation of Plp1YFP+ cells ventrally to the first TH+ cells and the lack of Plp1YFP+ cells
at the more overlying CART+ chain corresponding to the sympathoblasts of the sympathetic chain. (B,C,E) Immunofluorescence on cryosections against Plp1YFP,
CART and TH on an E15.5 embryo injected with TAM at E11.5 and analyzed at E15.5. Note the Plp1YFP+/TH+ cells in the Zuckerkandl organ (ZO), sympathetic
para-aortic ganglion (PAG, shown by white arrowheads) and adrenal medulla (AM). (D) Upper panel: immunofluorescence against Plp1YFP, SOX10 and CART on
peripheral nerves of E15.5 Plp1YFP+ embryos injected with TAM at E11.5. Lower: quantification of recombination efficiency in SOX10+ cells of peripheral nerves
(corresponding to total peripheral glial cells) of embryos TAM-injected on E11.5 and analyzed at E15.5 (69.63 ± 8.69%, N = 4). Filled arrowheads show
Plp1YFP+/SOX10+ glial cells and empty arrowheads show Plp1YFP−/SOX10+ glial cells. (F) Quantification of recombination in chromaffin and sympathetic
population in embryos TAM-injected on E11.5 and analyzed at E15.5 (for the ZO 44.77 ± 6.44%, anterior PAG 4.84 ± 1.38%, posterior PAG 11 ± 2.80%, AM
37.69 ± 5.46%, in all cases N = 4). Data are presented as mean ± SEM. Note the high percentage of Plp1YFP+/TH+ cells in the chromaffin organs ZO and AM and
the difference in percentage of Plp1YFP+/TH+ cells between the posterior and anterior PAG. Scale bar in (A) = 100 µm, in (B–E) = 50 µm. SA primordium,
sympathoadrenal primordium; ZO, Zuckerkandl organ; PAG (ant), para-aortic ganglion (anterior); PAG (post), para-aortic ganglion (posterior); AM, adrenal medulla.
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FIGURE 3 | A chromaffin body located between the suprarenal and mesenteric ganglion is Schwann-cell-precursor-derived. (A) Immunofluorescence on
cryosections against Plp1YFP, CART and TH on an E15.5 embryo injected with tamoxifen (TAM) at E11.5 showing the sympathetic ganglion (SG), suprarenal
ganglion (SRG) and mesenteric ganglion (MG). (B) Quantification of recombination in chromaffin and sympathetic population in embryos TAM-injected on E11.5 and
analyzed at E15.5 (SG 2.72 ± 0.65%, SRG 2.35 ± 1.04%, MG 1.96 ± 0.81%, TCB 45.09 ± 4.90%, in all cases N = 4). Data are presented as mean ± SEM. In TCB
vs. SG P = 0.0004, TCB vs. SRG P = 0.0003 and TCB vs. MG P = 0.0005. (C) Immunofluorescence on cryosections against Plp1YFP, CART and TH on an E15.5
embryo injected with TAM at E11.5 at the area of transition from the SRG to the MG, showing the “transitional chromaffin body” (TCB). Note the differential CART
and TH signal between the SRG and MG, as well as the Plp1YFP+/THhigh cells in the TCB. Note the high percentage of Plp1YFP+/TH+ cells in the TCB and the
absence of Plp1YFP+/TH+ cells in the SG, SRG and MG. Scale bar in (A,C) = 50 µm. SG, sympathetic ganglion; SRG, suprarenal ganglion; MG, mesenteric
ganglion; TCB, transitional chromaffin body; ∗∗∗P ≤ 0.001.
(Leone et al., 2003; Goebbels et al., 2010; Adameyko et al.,
2012; Dyachuk et al., 2014). It was previously shown that neural
crest migration is complete by E11.5 and at this stage there are
no neural crest cells at the embryo trunk which are multipotent
and can give rise directly to sympathetic neurons (Furlan et al.,
2017). Thus, in order to trace strictly SCPs and not neural crest
cells, we injected TAM at E11.5. This resulted in tracing of
SCPs along the nerves exiting the spinal cord and at the vicinity
of the SA primordium by E12.5 (Figure 2A). TAM injection
at E11.5 and analysis of the ZO at E15.5 revealed that SCPs
contributed by 44.7 ± 6.44% to these extra-adrenal chromaffin
cells (Figures 2B,F). Importantly, we also observed a small, but
significant percentage (11 ± 2.8% of the posterior para-aortic
ganglionic neurons) of sympathetic neurons at the posterior
levels of the trunk being traced (Figures 2C,F). In accordance to
previously described SCP-contribution to the adrenal medulla
(Furlan et al., 2017), 37.69 ± 5.47% of the adrenal medulla
cells were traced, while there was no tracing of the sympathetic
neurons of the anterior sympathetic ganglia and suprarenal
ganglion (SRG) or mesenteric ganglion (<2.8% of the total
sympathoblasts that compose the ganglia, Figures 2E,F, 3A,B).
Taking in consideration that the efficiency of recombination in
the total Schwann cell population along the nerves as seen by
SOX10+ immunoreactivity (Kuhlbrodt et al., 1998; Britsch et al.,
2001) was 69.63 ± 8.70% (Figure 2D), the total contribution of
SCPs to the sympathetic neurons of the posterior trunk might be
even greater.
Additionally, in Plp1YFP+ embryos traced from E11.5 and
analyzed at E15.5, we consistently observed a group of TH+
cells, located in the transition between the SRG and mesenteric
ganglion (Figure 3C). We termed this new cellular entity
as “transitional chromaffin body” (TCB). Even though the
TCB contained few THhigh/CART+ cells in addition to the
majority of THhigh/CART− cells, we excluded the possibility
of this group of cells being a sympathetic ganglion, since it
was composed of THhigh cells, typically a feature of early
chromaffin cells and not sympathoblasts (as compared to the
CARThigh/THlow cells of the SRG and CARTlow/THlow cells
of the mesenteric ganglion, Figure 3C) (Chan et al., 2016).
At the same time, almost half the cells of the TCB were
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 January 2019 | Volume 12 | Article 6
fnmol-12-00006 January 23, 2019 Time: 17:11 # 7
Kastriti et al. Nerve-Derived Origin of Zuckerkandl Organ
FIGURE 4 | Ablation of Schwann cell precursors or the preganglionic nerves that serve as their route toward the dorsal aorta results in a reduction of chromaffin cell
numbers of the Zuckerkandl organ. (A,B) Immunofluorescence on cryosections against CHAT (choline acetyltransferase) (upper panels) at the level of the spinal cord
shows the absence of CHAT+ (cholinergic) preganglionic motorneurons in the gray matter, also seen as absence of ISL1+ motorneurons (lower panel). Scale
bar = 100 µm. (C,D) Immunofluorescence against CART and TH at the level of the Zuckerkandl organ (ZO) shows a severely abnormal phenotype in the ZO and
para-aortic ganglia (PAG) in Hb9Cre/+;Isl2DTA/+ E14.5 embryos in comparison to Isl2DTA/+ control E14.5 embryos. Scale bar = 100 µm. (E) Quantification of TH+
cells at E14.5 in control Isl2DTA/+ and mutant Hb9Cre/+;Isl2DTA/+ embryos shows a decrease in the ZO and PAG, while the mesenteric ganglia (MG) remain
unaffected. In Isl2DTA/+ versus Hb9Cre/+;Isl2DTA/+ respectively: total TH+ cells in ZO = 426.6 ± 52.66 vs. 201.9 ± 27.43 (P = 0.0194), in MG = 178.4 ± 21.44 vs.
198.4 ± 15.34 (P = 0.4889) and in PAG = 133.1 ± 9.57 vs. 83.22 ± 5.79 (P = 0.0112), N = 3 per genotype. Data are presented as mean ± SEM and statistical
analysis was performed using two-tailed Student t-test. (F) Schematic showing the experimental design for induction of the visceral nerve ablation using the
Hb9Cre;Isl2DTA strain. (G,H) Immunofluorescence against SOX10, TH and neurofilaments (NF) on cryosections from Sox10CreERT2/+ and Sox10CreERT2/+;R26DTA/DTA
E17.5 embryos following tamoxifen (TAM) injection at E11.5 and E12.5 and analysis at E17.5 showing almost complete Schwann cell precursor (SCP)-ablation and
significantly abnormal morphology in ZO, PAG and MG. Scale bar = 100 µm. (I) Quantification of SOX10+ cells in control Sox10CreERT2/+ and SCP-ablated
Sox10CreERT2/+;R26DTA/DTA E17.5 embryos following TAM injection at E11.5 and E12.5 and analysis at E17.5. In Sox10CreERT2/+ vs. Sox10CreERT2/+;R26DTA/DTA
respectively: total SOX10+ cells in ZO = 205.47 ± 28.96 vs. 5.33 ± 4.43 (P = 0.0024), in MG = 369.33 ± 27.56 vs. 5.55 ± 5.22 (P = 0.0002) and in
PAG = 88.11 ± 6.46 vs. 3.24 ± 2.58 (P = 0.0002), N = 3 per genotype. Data are presented as mean ± SEM and statistical analysis was performed using two-tailed
Student t-test. (J) Quantification of TH+ cells in control Sox10CreERT2/+ and SCP-ablated Sox10CreERT2/+;R26DTA/DTA E17.5 embryos following TAM injection at
E11.5 and E12.5 and analysis at E17.5. In Sox10CreERT2/+ vs. Sox10CreERT2/+;R26DTA/DTA respectively: total TH+ cells in ZO = 588.08 ± 28.41 vs. 397.22 ± 23.69
(P = 0.0067), in MG = 243.66 ± 22.98 vs. 226.55 ± 15.24 (P = 0.5685) and in PAG = 103.00 ± 7.61 vs. 94.11 ± 8.04 (P = 0.4672), N = 3 per genotype. Data are
presented as mean ± SEM and statistical analysis was performed using two-tailed Student t-test. (K) Schematic outlining the TAM injection times and collection
time point in the Schwann cell precursor (SCP)-ablation experiment using the Sox10CreERT2;R26DTA strain. SC, spinal cord; GM, gray matter; MG, mesenteric
ganglion; PAG, para-aortic ganglion; MNs, motorneurons; DA, dorsal aorta; ZO, Zuckerkandl organ; ns, non-significant; ∗P ≤ 0.05; ∗∗P ≤ 0.01; ∗∗∗P ≤ 0.001.
Frontiers in Molecular Neuroscience | www.frontiersin.org 7 January 2019 | Volume 12 | Article 6
fnmol-12-00006 January 23, 2019 Time: 17:11 # 8
Kastriti et al. Nerve-Derived Origin of Zuckerkandl Organ
FIGURE 5 | Ascl1 is indispensable for differentiation of Schwann cell precursors toward chromaffin cells of the Zuckerkandl organ. (A,B) Immunofluorescence
against CART, Ascl1TOM and TH on cryosections of tamoxifen (TAM)-injected embryos at E10.5 and analyzed at E15.5 shows a decrease in TH+/Ascl1TOM+ cells in
the region of the Zuckerkandl organ (ZO) in mutant Ascl1CreERT2/CreERT2;R26TOM/+ embryos in comparison to control Ascl1CreERT2/+;R26TOM/+ embryos, as well as
increased CART+/Ascl1TOM+ cell numbers (shown by white arrowheads) and absence of the para-aortic ganglia (PAG). (C) Immunofluorescence against S100B,
Ascl1TOM and SOX10 on cryosections of TAM-injected embryos at E10.5 and analyzed at E15.5 shows an accumulation of S100B+/SOX10+/Ascl1TOM+ cells in the
region of the ZO in mutant Ascl1CreERT2/CreERT2;R26TOM/+ embryos that are absent in control Ascl1CreERT2/+;R26TOM/+ embryos. Scale bar in (A) and in upper
panel of (C) = 100 µm, in (B) = 50 µm and in magnified insets in (C) = 25 µm. (D,E) Schematic depicting the main findings upon Ascl1 ablation and tracing of the
Ascl1-progeny. The Ascl1TOM lineage traced from E10.5 gives rise mainly to chromaffin cells (TH+) and sympathetic neurons (CART+) in control embryos. In
contrast, in mutant embryos, the majority of Ascl1TOM cells remains as glia (S100B+/SOX10+), with a small population of CART+ cells that is not seen in the control,
and very few chromaffin cells (TH+) are produced. PAG, para-aortic ganglion; DA, dorsal aorta; ZO, Zuckerkandl organ; MG, mesenteric ganglion.
Plp1YFP+ when traced starting from E11.5 (45.08% of the total
cells), indicating that they are SCP-derived (Figures 3B,C).
Interestingly, observation of the surrounding sympathetic
neurons of the SRG and mesenteric ganglion revealed significant
higher CART levels in the SRG compared to the mesenteric
ganglion (Figure 3C).
The adrenal gland receives innervation from the cholinergic
(neurons positive for choline acetyltransferase – CHAT+)
preganglionic neurons of the spinal cord (Parker et al., 1993).
Due to the compactness of the first TH+ chromaffin cells (or
else SA primordium) (Figure 2A), we reasoned that potentially
the same fibers innervate the ZO. In order to test this and
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FIGURE 6 | The development and anatomy of the Zuckerkandl organ and associated paraganglia in relation to the dorsal aorta. (A) Schematic showing the
molecular differences and similarities between sympathetic neurons (SNs) and chromaffin cells (ChCs) during development in relation to the expression of CART,
(Continued)
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FIGURE 6 | Continued
ISL1 and TH. (B) Side-view of whole-mount immunofluorescence against smooth-muscle-actin (SMA, showing the dorsal aorta -DA), TH and CART on an E12.5
wild type embryo. Note the presence of TH+ cells at the dorsal part of the DA just posteriorly to its branching into the inferior mesenteric artery (shown by the white
arrowhead). (C) Immunofluorescence on E12.5 wild type embryos against SOX10 and TH (left panel) and SOX10, CART and ISL1 (right panel) showing the close
proximity of the developing CART-/ISL1+/TH+ Zuckerkandl organ (ZO) and CART+/ISL1+/TH+ mesenteric ganglion (MG). (D) Ventral-view of whole-mount
immunofluorescence against NF200, TH and CD31 (showing the endothelium of the DA) on an E12.5 wild type embryo. Note the presence of the ZO below the
inferior mesenteric artery (shown by the white arrowhead), which is surrounded by NF200+ axons. (E) Immunofluorescence on cryosection of an E13.5 wild type
embryo against NF200, TH and CART. Note the innervation pattern around the DA and the TH+ cells of the ZO. (F) Ventral-view of whole-mount
immunofluorescence against SMA, TH and CART on an E13.5 wild type embryo. Note the close proximity of the MG and ZO just posteriorly to the inferior
mesenteric artery and the separation of the two structures based on the CART+/THlow immunoreactivity in the MG in contrast to the THhigh immunoreactivity of the
ZO (shown by the white arrowhead). Also note the presence of THhigh chromaffin structures in close proximity to the MG and ZO (shown by yellow arrows).
(G) Immunofluorescence against CART, TH and DAPI on cryosections of a wild type E17.5 embryo, clearly showing the composite nature of the ZO at this later
developmental stage, with both TH+/CART- and TH+/CART+ cells. Scale bar = 100 µm. SNs, sympathetic neurons; ChCs, chromaffin cells; SC, sympathetic chain;
DA, dorsal aorta; PAG, para-aortic ganglion; ZO, Zuckerkandl organ; AM, adrenal medulla; MG, mesenteric ganglion.
to further confirm that the Plp1YFP+ cells, which contributed
to ZO and paraganglia, were nerve-associated SCPs, we used a
genetic model for specific ablation of these nerves. To achieve
this, we utilized the Hb9Cre;Isl2DTA strain. In this strain, Hb9+
preganglionic visceral neurons start express Isl2-driven DTA
(Diptheria Toxin Subunit A) as soon as they exit cell cycle,
resulting to their death (Yang et al., 2001; Thaler et al., 2004;
Furlan et al., 2017) (Figures 4A,B,F). As a result, the nerves that
serve as routes for SCPs to arrive at the SA anlage are ablated to a
significant extent. Upon loss of the preganglionic motorneurons
and analysis at E14.5, we observed a significant reduction of the
total TH+ cells of the ZO (52.72% reduction) and para-aortic
sympathetic ganglia (37.47% reduction), while the mesenteric
ganglia remained unaffected (Figures 4C–E).
Next, to exclude any potential secondary effect of the nerve
ablation on the development of the ZO due to the lack of
trophic factors produced by the nerve, we performed SCP-
ablation experiments by means of the Sox10CreERT2;R26DTA
strain. To induce a significant decrease in SCPs (all of which
are SOX10+), we injected TAM both at E11.5 and E12.5
(Figure 4K). Analysis of the SCP-ablated embryos was performed
at E17.5 and showed a significant loss of glial (SCP) SOX10+
cells in ZO and the surrounding mesenteric and para-aortic
sympathetic ganglia (Figures 4G–J). Upon SCP-ablation, ZO
was significantly affected, as shown by a 32.45% decrease in
total TH+ cell numbers. However, even though an abnormal
morphology was observed for the mesenteric and para-aortic
ganglia, the changes in TH+ numbers and the overall reduction of
these two sympathetic structures were not statistically significant
(Figures 4G–J).
Thus, both types of experimental approaches of blocking the
delivery of SCPs to the SA anlage (either by ablating the delivering
nerve or by ablating the SCPs themselves) demonstrated an
effect on ZO chromaffin and possibly sympathetic cells and no
significant effect on other sympathetic ganglia of the region.
The current belief supports that the neurons of the
sympathetic nervous system are derived from the neural crest.
However, a variety of observations hint that at least a small
proportion of the sympathetic neurons at the posterior trunk
are derived from SCPs. Firstly, upon TAM injection at E11.5 in
Plp1YFP mice, we find a 5–10% tracing of the sympathetic neurons
of the para-aortic ganglia. Secondly, we observe a noticeable
reduction in the size of the para-aortic ganglia upon ablation
of the visceral motorneurons, which are responsible for the
delivery of SCPs to the SA anlage. However, glial ablation by TAM
injection at E11.5 and E12.5 does not seem to significantly affect
these ganglia, which could be due to the non-extensive expression
of the transgene in this population.
Ascl1 Is Indispensable for SCP
Differentiation to Chromaffin Cells of the
ZO
Previous studies have highlighted the importance of Ascl1
(also known as Mash1) in the transition of SCPs to mature
neuroendocrine TH+ chromaffin cells residing in adrenal
medulla (Huber et al., 2002a; Furlan et al., 2017). Additionally,
the gene is also indispensable for the development of sympathetic
ganglia of the autonomic nervous system.
The lineage tracing experiments proved that Ascl1+
progenitors contribute to the development of ZO (Figure 1D),
and suggested that the absence of Ascl1 should inhibit the
differentiation of SCPs toward chromaffin cells in ZO. In order
to examine this, we used the knock-in Ascl1CreERT2;R26TOM
strain, where the coding sequence of the Ascl1 gene is replaced by
CreERT. At the same time, both heterozygote and homozygote
embryos express Ascl1TOM, which allows to track the progeny of
the cells that lack Ascl1, in the case of the homozygosity.
As expected, embryos which received TAM at E10.5 and
were analyzed at E15.5, revealed tracing in the sympathetic
compartment and a portion of the ZO chromaffin cells
in heterozygous control embryos (Ascl1CreERT2/+;R26TOM/+)
(Figure 5A). Contrary to this, homozygous mutant embryos
(Ascl1CreERT/CreERT2;R26TOM/+) lacked the mesenteric ganglion
and para-aortic sympathetic ganglia located above the dorsal
aorta and featured an obvious decrease of TH+ chromaffin
cells in ZO (Figures 5A,B). Furthermore, in the location of
the mutant ZO, we observed TH+/CARThigh/Ascl1TOM+ and
TH−/CARThigh/Ascl1TOM+ cells almost uniquely in mutant
embryos, which might mean that Ascl1 is also involved in the
downregulation of sympathetic-like markers such as CART in
immature progenitors in order for them to differentiate into
mature TH+/CART− cells, or that a very small portion of the
mesenteric ganglion was formed but did not separate from the
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 January 2019 | Volume 12 | Article 6
fnmol-12-00006 January 23, 2019 Time: 17:11 # 11
Kastriti et al. Nerve-Derived Origin of Zuckerkandl Organ
future ZO. In heterozygotes, few TH−/CART+/Ascl1TOM+ cells
were observed only within the mesenteric ganglion, located just
next to the dorsal aorta, above the ZO and were not included
in the analysis of the ZO (Figure 5A). Furthermore, analysis of
E15.5 embryos using the SCP (glial) markers S100B and SOX10
revealed an accumulation of S100B+/SOX10+/Ascl1TOM+ SCPs
in mutant embryos, which were almost absent in control embryos
(Figure 5C).
These results suggest that in the absence of Ascl1, the SCPs that
serve as progenitors of the future chromaffin cells are not able to
differentiate and are abnormally accumulating either in the SCP
stage (as shown by the presence of S100B+/SOX10+/Ascl1TOM+
cells in the mutant) or in the transition from an immature
neuroblast-like cell to a mature chromaffin cell (as seen by the
numerous CART+/Ascl1TOM+ cells in the mutant within the
abnormal ZO) (Figures 5D,E).
Anatomical Complexity of ZO and
Associated Sympathetic Paraganglia
The ZO is thought to be a chromaffin organ with similar
properties to those of the adrenal medulla. However, the close
association of the ZO with the dorsal aorta, its direct exposure to
the environment due to the lack of a surrounding cortex, as well
as its transient appearance as opposed to the adrenal medulla,
suggest that it may have functions that have not been addressed.
An element of complexity toward the study of the ZO is the fact
that the main marker of chromaffin cells, TH, is also expressed
by the vast majority of embryonic sympathetic neurons. Thus,
only recent developments and discoveries have made it possible
to study the ZO in a new light, such as single-cell data of the
SA region during mid-gestation in mice and mature sympathetic
neurons in adult mice (Furlan et al., 2016, 2017). The mentioned
studies showed that the sympathoblasts are different from the
chromaffin cells in terms of gene expression and brought to light
markers that would discriminate between the two, such as CART,
which was also supported by a previous study (Chan et al., 2016)
(Figure 6A).
Even though our data show that the ZO and the AM share
the SCP-origin, they also hint that the ZO might be a composite
organ, as seen by CART+ immunoreactivity at the posterior part.
To reveal the developmental dynamics of ZO and in order
to address whether the developing chromaffin component of
the ZO associates with sympathetic structures while eventually
integrating into them, we sought out to analyze extensively its
development and location in relation to the sympathetic ganglia
of the mid-trunk in various developmental stages.
Whole-mount immunofluorescence and immunofluorescence
on cryosections using the sympathetic and chromaffin pan-
marker TH and the sympathetic-specific marker CART at E12.5
placed the primordium of the developing ZO and adrenal
medulla nearby sympathetic para-ganglia at the ventral part of
the dorsal aorta (Figure 6B). At this stage, the two populations
are in proximity and are found at the mid-level of the kidneys. We
noticed that already at E12.5, a large population of CART−/TH+
cells is located below the branching of the dorsal aorta toward
the inferior mesenteric artery (Figure 6B), clearly separated by
the smaller CART+/TH+ population that corresponds to the
sympathetic para-ganglia that have already been fate-defined
(Figure 6C).
Additionally, whole-mount analysis of E13.5 embryos,
as well as analysis on cryosections, revealed an elaborate
innervation of the developing ZO (Figures 6D,E). Whole-
mount immunostaining experiments at E13.5 demonstrated
that the inferior mesenteric artery is not only surrounded by
ZO (as shown by high TH+ immunofluorescence), but also
by the mesenteric sympathetic ganglia (CART+/THlow), which
previously might have been considered a part of the ZO at this
stage (Figure 6F). Additionally, we also detected bilateral groups
of CART−/THhigh cells that are not a part of ZO (Figure 6F,
yellow arrows), and those cells have not been described in the
literature before.
The complexity of the chromaffin and sympathetic
structures of the mid-trunk becomes even more obvious upon
examination of single cross-sections at the level of ZO at
later developmental stages. The ZO is a continuously growing
organ, reaching the maximum of chromaffin cell numbers
just before birth in rodents (Schober et al., 2013). Notably,
at E17.5, the sympathetic marker CART, which helped to
differentiate between the sympathetic and chromaffin cells with
high fidelity in earlier stages, shows immunoreactivity within
the chromaffin population of ZO (Figure 6G). This observation
might point to the hypothetical existence of several stages in
the maturation of chromaffin cells that compose ZO or even
hint that the organ might undergo fate reprogramming during
late embryonic stages. Last but not least, these data suggest
that ZO is not strictly a chromaffin population, but is likely to
be a composite organ at the fullest of its maturity, consisting
of chromaffin cells, undetermined bipotent sympatho-adrenal
progenitors, peripheral glial cells and a fraction of sympathetic
neurons.
Thus, our analysis shows for the first time the developmental
complexity of the ZO, as well as the existence of a variety
of chromaffin accumulations in its vicinity that do not seem
to belong to ZO itself. Additionally, even though the ZO
shares many similarities with the adrenal medulla, it is a more
heterogeneous cellular population than the adrenal medulla,
with a potential sympathetic-like component. Considering the
classification of tumors that are found in the area of the ZO,
our results are pointing to the possibility of a misclassification of
some of these cancers. The existence of additional extra-adrenal
chromaffin cellular accumulations, apart from the ZO, as well
as the CART+ component of the ZO suggests that there are
alternative cellular sources of PGG and PCC as those that were
considered until now.
MATERIALS AND METHODS
Mouse Strains and Husbandry
In all experiments, the day of plug detection was considered
as E0.5. All experiments were performed under the permission
of the Ethical Committee on Animal Experiments (Stockholm
North committee) and according to The Swedish Animal
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Agency’s Provisions and Guidelines for Animal Experimentation
recommendations.
Tamoxifen-Inducible CreERT2 Strains
Sox10CreERT2 were received from V. Pachnis laboratory (The
Francis Crick Institute, United Kingdom) (MGI ID: 5301107).
RetCreERT2 mice were received from D. Ginty laboratory (Harvard
University, United States) (MGI ID: 4437245). Plp1CreERT2 were
received from U. Suter laboratory (ETH Zurich, Switzerland)
(MGI ID: 2663093). Ascl1CreERT2 mice (a knock-in strain where
the Ascl1 coding region is replaced by the CreERT2 sequence)
were received from The Jackson Laboratory (stock 012882).
Cre-Dependent Reporter Strains
R26RTomato and R26RYFP mice were ordered from The Jackson
Laboratory (stock numbers 007914 and 006148 respectively).
All tracing experiments using inducible CreERT2 lines (Plp1,
Sox10, Ret and Ascl1-driven) were performed using heterozygotes
for both the CreERT2 and the reporter R26RYFP or R26RTOMATO.
Strains Used in Cholinergic Preganglionic
Motorneuron Ablation Experiments
For targeted ablation of the preganglionic neurons, Isl2DTA
mice were bred to Hb9Cre mice to generate experimental
Hb9Cre/+;Isl2DTA/+ and control Isl2DTA/+ embryos.
HB9Cre mice were received from The Jackson Laboratory
(stock 006600). Isl2DTA mice were received from The Jackson
Laboratory (stock 007942).
Strains Used in Glia (SCP)-Ablation Experiments
For the glia ablation using the Sox10CreERT2;R26DTA strain,
all embryos were bred heterozygotes for the Sox10CreERT2 (V.
Pachnis laboratory, The Francis Crick Institute, United Kingdom,
MGI ID: 5301107) but homozygous for the R26DTA (stock
006600).
Tamoxifen Dosage and Injection
To induce Cre-dependent recombination, tamoxifen (TAM)
(Sigma, T5648) was dissolved freshly in corn oil (Sigma, Cat
No 8267) as a 20 mg/mL stock and pregnant females received
intraperitoneal (i.p.) injections during the desired embryonic
stage (0.1 mg of TAM/g of body weight). When injecting at two
time points, the total dose was divided into the course of 2 days.
Embryo Collection and Preparation
Embryos were collected by evisceration from the uterus and a
small incision was made at the region of the abdomen to allow
penetration of the solutions. Then, the embryos were washed
in ice-cold PBS (pH 7.4) and fixed in 4% paraformaldehyde
(pH 7.4) in PBS at 4◦C with mild rotation, with a total fixation
duration adjusted to the developmental stage (3 h for E12.5 and
E13.5 embryos, 5 h for E14.5 and E15.5 embryos, O/N for E17.5
embryos). Samples were washed in PBS three times at 4◦C for 1 h
in total.
In the case of desired collection of cryosections, the samples
where cryoprotected by incubating at 4◦C overnight in 30%
sucrose in PBS until sinking. Next, tissue samples were embedded
in OCT and frozen at−20◦C.
In the case of whole mount immunofluorescence, the embryos
were washed in PBS containing 0.1% Tween−20 (PBST) three
times at room temperature, 10 min each time, before proceeding
to the whole mount preparation.
Immunofluorescence on Cryosections
Tissue samples were embedded in OCT and frozen at −20◦C.
Tissue was sectioned on the cross-sectional plane at 14–25 µm
and frozen at −20◦C after drying at room temperature for at
least 1 h. Antigen retrieval was performed by incubation of
the sections in 1x Target Retrieval Solution (Dako, S1699) for
20 min, pre-heated at 80◦C. Sections were washed three times
in PBST, 5 min each time, and incubated at 4◦C overnight
with primary antibodies diluted in PBST. Finally, sections were
washed three times in PBST, 5 min each, and incubated with
secondary antibodies diluted in PBST at room temperature for
1 h, washed three times in PBST and mounted using Mowiol
mounting medium.
Primary Antibodies Used
Rabbit anti-TH (1:1000, Pel-Freez Biologicals, #P40101-150),
sheep anti–TH (1:2000, Novus Biologicals, #NB300-110), mouse
anti-TH (1:2000, Sigma, #T2928), mouse monoclonal anti-
bIII tubulin (1:500, Promega, #G712A), goat anti-GFP (1:500,
Abcam, #ab6662), chicken anti-GFP (1:500, Aves Labs Inc.,
#GFP-1020), chicken anti-mCherry (1:1000, EnCor Biotech,
#CPCA-mCherry), goat anti-SOX10 (1:500, Santa-Cruz, #sc-
17342), rabbit anti-S100β (1:500, DAKO, #Z0311), mouse anti-
ISL1 (1:250, DSHB, clone 39.4D5-s), rabbit anti-CART (1:500,
Phoenix Pharma., #H-003-62), goat anti-CHAT (1:100, Millipore,
#AB144P), mouse anti-CD31 (1:200, Dako, clone JC70A), rat
anti-CD31 (1:200, BD Pharmingen, #553370), mouse anti-SMA-
Cy3 (1:500, Sigma, #C6198), chicken anti-NF200 (1:1000, Abcam,
#ab4680).
When DAPI (Sigma, D9542) was used, it was diluted in PBS
to a concentration of 0.1 mg/mL and applied on the sections at
the same time as the secondary antibodies. For detection of the
primary antibodies, secondary antibodies raised in donkey and
conjugated with Alexa-488, -555 and -647 fluorophores were used
(1:1000, Molecular Probes, Thermo Fisher Scientific).
Whole Mount Immunofluorescence
Whole mount fluorescent immunostaining of mouse embryos,
3D imaging and visualization were performed as previously
described (Adameyko et al., 2012). Briefly, following fixation and
PBST washes (see section “Embryo Collection and Preparation”),
the samples were progressively dehydrated by incubation at room
temperature at 25, 50, 75% and then 100% methanol (MetOH)
(1 h incubation per concentration). Then, autofluorescence from
the blood was bleached with incubation in Dent’s bleach (one part
30% H2O2/two parts Dent’s fix) (Dent’s fix: 20% DMSO in 80%
MetOH) at 4◦C for 24 h. Next, samples were washed in MetOH
at room temperature five times, 10 min each and fixed in Dent’s
fix for another 24 h at 4◦C.
On the day of the staining, the samples were washed in
PBST at room temperature three times, 20 min each. Embryos
were incubated with the primary antibodies diluted into blocking
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solution (5% of normal donkey serum, 20% DMSO in PBS) for
a week, at room temperature. Following incubation with the
primaries, samples were washed in PBST for six times, 30 min
each at room temperature and incubated for 2–3 days with
secondary antibodies in blocking solution, at room temperature.
Upon completion, embryos were washed six times, 30 min each
in PBST, dehydrated by incubation for 5 min in 50% MetOH and
an hour in 100% MetOH. Prior to imaging, samples were cleared
using BABB solution (one part of benzyl alcohol/two parts of
benzyl benzoate) for 1 h at room temperature with rotation prior
to imaging in BABB.
Microscopy
Images were acquired using LSM700, LSM 710, LSM 780, LSM
880 Zeiss confocal microscopes equipped with 10x, 20x, 40x,
and 63x objectives. Images were acquired in the.lsm format and
processed with FIJI (Schindelin et al., 2012).
Statistics
Data were analyzed using GraphPad Prism (v 7.02) and expressed
as mean ± standard error of mean. Statistical significance was
calculated by two-sided t-tests without assuming a consistent SD
and represented as follows: ∗p-value ≤ 0.05; ∗∗p-value ≤ 0.01,
∗∗∗p-value ≤ 0.001. Sample size ranged from 3 to 4 biological
replicates.
DISCUSSION
The ZO is a large accumulation of chromaffin cells, which, unlike
the adrenal medulla, is surrounded by sympathetic structures
and is lacking an equivalent of the adrenal cortex. The organ
appears to have an important role during embryonic and very
early postnatal development, releasing catecholamines into the
circulation and it regresses following birth (West et al., 1953;
Schober et al., 2013). However, during gestation, the adrenal
gland forms almost simultaneously with the ZO, posing questions
about why a secondary source of catecholamines would be
necessary. A plausible explanation is that the ZO matures faster
than the adrenal gland and is capable of providing an additional
source of catecholamines during critical developmental periods.
Another possibility is that the ZO is the evolutionary remnant
of the first chromaffin cells in Agnatha, prior to the emergence
of the mesodermal adrenal cortex, which surrounds the adrenal
chromaffin cells.
Importantly, the co-existence of the sympathetic para-ganglia
and the chromaffin ZO in such proximity without a clear
spatial separation, as in the case of the adrenal medulla and the
suprarenal ganglion, pointed to a potential common origin of the
two components. For decades, it was believed that sympathetic
neurons and chromaffin cells of ZO were derived from freely
migrating neural crest cells, which migrate around the dorsal
aorta and acquire their differential identity as a response to
signals secreted from the dorsal aorta (Huber et al., 2009; Saito
et al., 2012). However, some more recent data pointed to an
alternative mechanism: the progenitors of the SA lineage are
heterogeneous prior to final steps of migration and express
different markers before they reach the SA anlage (Ernsberger
et al., 2005; Chan et al., 2016). This knowledge points to the
existence of at least two lineages of progenitors giving rise to
sympathetic and chromaffin cells respectively.
Numerous genes have been found dispensable for normal
development of the SA system (Huber, 2006). Such an example
is the tyrosine kinase receptor RET, which is expressed
by SA progenitors at early embryonic stages and is later
downregulated in chromaffin cells while persisting in sympathetic
neurons (Pachnis et al., 1993; Allmendinger et al., 2003).
Additionally, Ret knock-out mice exhibit defective migration
and neurite elongation of sympathetic neurons but no defect in
chromaffin cell numbers or ultrastructure (Enomoto et al., 2001;
Allmendinger et al., 2003). In accordance to these observations,
by using the RetCreERT2;R26TOM strain and injecting TAM at
E10.5 and E11.5, 24- and 48-h prior to the detection for the first
chromaffin cells in the SA primordium, we showed that at E15.5
RetTOM was expressed specifically in the sympathetic ganglia
and was almost absent in the ZO chromaffin cells, suggesting
a lineage split of SA progenitors as early as E10.5. This urged
us to investigate more genes that have been involved in the
SA progenitor lineage. A gene that is indispensable for both
sympathoblasts and chromaffin cells is Ascl1 (Mash1) (Huber
et al., 2002a). Next, using the inducible Ascl1CreERT2;R26TOM
strain, we observed that recombination at E11.5 resulted in
Ascl1TOM+ cells found only in the ZO. Thus, our results
showed an established lineage separation between sympathetic
and chromaffin progenitors at around E10.5 and E11.5, a time
point at which only SOX10+ cells are detected at the adrenal
gland anlage but no TH+ cells (Lumb et al., 2018). At those
stages, neural crest cells have completed their migration and no
longer exist as freely migrating (Furlan et al., 2017), pointing to
an alternative progenitor that is not a neural crest cell.
In line with this, recent studies have brought forward a
new type of multipotent cells, the nerve-associated Schwann
cell precursors (SCPs). SCPs are multipotent cells that are
able to generate a variety of cell types during development,
ranging from melanocytes, medullary chromaffin cells and
parasympathetic neurons, glomus cells of the carotid organ,
enteric neurons and even endoneural fibroblasts, Schwann
cells and some mesenchymal populations (Jessen and Mirsky,
2005; Jessen et al., 2008; Adameyko et al., 2009; Laranjeira
et al., 2011; Dyachuk et al., 2014; Espinosa-Medina et al.,
2014; Isern et al., 2014; Kaukua et al., 2014; Uesaka et al.,
2015; Furlan et al., 2017; Hockman et al., 2018). Thus, SCPs
use the peripheral nerves to reach specific locations in the
developing embryo, which is continuously growing in size and,
in a way, are able to functionally replace neural crest cells
at late time points of development (Furlan and Adameyko,
2018).
In agreement with these studies, our results showed a
new SCP-contribution to ZO, as well as to a small fraction
of posterior-trunk sympathoblasts. Lineage tracing induced
in Plp1CreERT2;R26YFP embryos at E11.5, a time when no
neural crest cells are found anymore except at the tip of the
tail, revealed recombination of roughly half the chromaffin
cells of the ZO, while no tracing was observed in most
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sympathetic structures such as the suprarenal ganglion, the
mesenteric ganglion and anterior part of the sympathetic
chain. Unexpectedly, we also noticed recombination in a small
fraction of posterior sympathetic ganglia (around 10% of all
sympathoblasts posteriorly to the inferior mesenteric artery).
This observation shows that there is a mixed origin of the
sympathetic neurons at the posterior part of the body, which
was never described so far, since common belief was that all
sympathetic neurons are neural-crest-derived. Even though the
evolutionary or functional reason for this adaptation is not clear,
we hypothesize that it may provide some additional heterogeneity
in the sympathetic compartment. To obtain further confirmation
of the SCP involvement in ZO development, we injected TAM
at E11.5 and E12.5 in mice of the Sox10CreERT2;R26DTA strain
and analyzed them at a much later developmental stage (E17.5).
This genetic manipulation allowed for almost total glial ablation,
as seen by the numbers of SOX10+ cells and resulted in a
significant decrease in the total chromaffin cell numbers of the
ZO, but left all sympathetic ganglia unaffected. However, this is
not surprising, when taking in consideration the low proportion
of sympathoblasts that are derived from the Plp1+ lineage.
Targeted SCP-ablation might be compensated in the sympathetic
component through increased proliferation of the remaining
neuroblasts during development.
Ascl1 is a key transcription factor that is necessary for the
development of both sympathetic and chromaffin cells (Huber
et al., 2002a). Ascl1 is considered to be on top of the gene
hierarchy that controls the SA cell fate acquisition, expressed
by sympathetic and parasympathetic autonomic neurons, as
well as, chromaffin cells (Lo et al., 1991; Guillemot and
Joyner, 1993) and is necessary for the initiation of Th and
Dbh expression (Hirsch et al., 1998; Lo et al., 1998). Taken
together, these studies suggest that Ascl1 ablation should lead
to the accumulation of defective progenitors of the SA fates
that are not able to differentiate into Th-expressing cells. In
that case, we should be able to detect multiple Ascl1+ SCPs
in the ZO anlage. To examine this hypothesis, we used the
targeted CreERT2 knock-in strain Ascl1CreERT2;R26TOM, which
allows the study of the fate of mutant Ascl1−/− cells. Indeed,
in Ascl1CreERT2/CreERT2;R26TOM/+ mutant embryos at E15.5,
following TAM injection at E10.5, we observed a plethora of
glial-marker-expressing Ascl1TOM+ cells that were in much fewer
numbers in the control Ascl1CreERT2/+;R26TOM/+ embryos,
accompanied by a significant decrease in TH+ cell numbers.
Moreover, we observed an increase of CART+/Ascl1TOM+ cells
in the ZO, even though sympathetic ganglia were completely
absent in the mutant. We hypothesize that these cells represent
an intermediate transition state between the SCPs and fully
differentiated CART−/TH+ chromaffin cells. If this holds true, it
would give an interesting insight into the evolutionary emergence
of chromaffin cells from sympathetic cells that were found
dispersed in the body.
Next, we wondered how SCPs reach the developing
ZO primordium. Early on during embryonic development,
chromaffin cells and sympathetic neurons receive innervation
from the cholinergic preganglionic neurons of the
intermediolateral (IML) column of the spinal cord gray
matter. We thus hypothesized, that these nerves could serve
as the delivery mechanism of the SCPs to the primordium of
the forming ZO. To test this, we used the transgenic strain
Hb9Cre;Isl2DTA to ablate the neurons of the IML. Nerve ablation
resulted in significant chromaffin cell loss in the ZO and a
mild phenotype in the posterior sympathetic ganglia, indicating
that at least some component of the ZO must also be neural-
crest derived or that some of the SCPs reached the forming
ZO just before the nerve underwent apoptosis. Moreover, we
observed that the ZO was composed from CART−/TH+ cells
and CART+/TH+ cells, and that both subtypes were significantly
reduced upon the visceral nerve ablation. This observation
points to the composite nature of the ZO itself, an idea which has
been hinted in the past but only due to its association with the
sympathetic ganglia around the dorsal aorta. The heterogeneity
of the cells composing the ZO might be what makes it differ from
the adrenal medulla and could explain its transient role during
embryonic development, since a mixture of sympathetic and
chromaffin cells could operate as a functional unit of extensive
catecholamine and neuropeptide release.
Chromaffin cells and sympathetic neurons share Th and
Dbh expression, genes coding for enzymes that are involved in
noradrenaline synthesis. Despite the numerous similarities, it
has also been shown that several morphological characteristics
and molecular properties define the two cell types (Huber, 2006;
Chan et al., 2016; Furlan et al., 2017). The most pronounced
characteristics of chromaffin cells that differentiated them from
sympathetic neurons was considered the lack of neurites and the
presence of dense vesicles filled with catecholamines (also known
as chromaffin granules). However, in recent years, technical
advancements allowed for single-cell transcriptomic analysis of
many cell types and organs, among which are the developing
SA system and the postnatal sympathetic ganglia in the mouse
(Furlan et al., 2016, 2017). These studies resulted in a large
array of data that revealed many more differences between
sympathetic neurons and chromaffin cells on the molecular level.
However, thus far, these unique markers have not been used
to obtain new information about the placement of ZO and
associated sympathetic ganglia. In an attempt to examine their
organization in space, we performed an array of experiments on
whole embryo trunks during early stages of SA development,
ranging from E12.5 to E13.5. These clarified the relative position
of the mesenteric ganglia and ZO, as well as some TH+ cells in
the vicinity that have not been described thus far, showing even
more clearly the complexity of sympathetic ganglia and extra-
adrenal chromaffin bodies. Additionally, we were able to detect
a thus far unknown chromaffin body, which we decide to name
“transitional chromaffin body” (TCB). As the name suggests, TCB
is a small group of THhigh cells that is found at the transition
from the SRG toward the mesenteric sympathetic ganglion at
E15.5 embryos. The cells comprising the TCB were also SCP-
derived, as showed Plp1YFP+ tracing from E11.5. Additionally,
the 3D analysis of the area revealed previously undescribed
extra-adrenal chromaffin populations in close association with
the kidneys. Thus, we show that there are more extra-adrenal
chromaffin bodies than those which have been described so far.
Furthermore, our 3D analysis of the developing trunk along
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the antero-posterior axis revealed a mix of chromaffin and
sympathetic-like cells in the ZO and the clear separation between
the ZO and the sympathetic mesenteric ganglion, despite the
proximity and simultaneous development of the two structures.
Thus, the ZO is found constantly in the vicinity of sympathetic
neurons, in contrast to the adrenal medulla, which is well
separated from the sympathetic suprarenal ganglion by means
of the adrenal cortex. The importance of sympathetic neurons
and chromaffin cells and the ability to differentiate with precision
between the two lies in their association with special cancer
types found in the clinics, namely PGG and PCC. Currently,
these quite diverse cancer types are classified as such based on
their location and what seems like their origin at the time of
diagnosis. Specifically, PCCs are tumors that are found associated
with the adrenal gland, while PGGs are extra-adrenal tumors
(Lloyd et al., 2017). PGGs (also referred to as “extra-adrenal
pheochromocytoma”) are usually found in the vicinity of the
kidneys, even though many other “atypical” locations of such
tumors have been described such as peri-adrenal and para-aortic.
Apart from these, numerous cases of ZO-associated PCCs or
PGGs have been described, making even clearer the need of
new classification methods using specific markers rather than
just the location of the tumor (Altergott et al., 1985; Martucci
and Pacak, 2014). Surprisingly, the diagnostic markers for both
PCC and PGG are in many cases common and recent approaches
for the molecular classification of these tumors are considering
both types as one entity (Fishbein et al., 2017). However, the
differences between the sympathetic and chromaffin lineages are
not negligible and such approaches that consider the PGG- and
PCC-composing cells similar might not be correct. Until recently,
due to the notion that all these structures (the ZO, adrenal
medulla and sympathetic neurons), were derived from neural
crest cells, these cancer types were thought to be originating
from a common progenitor. However, our study, combined
with others showed that most chromaffin cells in the body are
derived from SCPs, pointing to the fact that SCPs can be one of
the initiating tumorigenic cell types (Furlan et al., 2017; Lumb
et al., 2018). Additionally, we show that the cells composing
the adrenal medulla and ZO have the same origin but might
be, in fact, quite different. Thus, the tumor-initiating cells could
be SCPs, chromaffin cells, sympathetic-like chromaffin cells or
sympathoblasts. In the future, proper classification of any cancer
type associated either with sympathetic or chromaffin lineages
may allow more selective and more effective treatment.
CONCLUSION
We focused on the comparative study of the development of the
extra-adrenal chromaffin ZO and the surrounding sympathetic
ganglia. By employing a variety of complementary approaches,
we show for the first time, that the chromaffin cells of the ZO
are SCP-derived, in contrast to the majority of the sympathetic
neurons of the trunk. Unexpectedly, we also observed that
a minority of sympathetic neurons around the posterior-
most level of the dorsal aorta is SCP-derived. Our results, in
combination with previous studies, suggest that the generation
of neuroendocrine cells from SCPs might be favored during the
evolution of vertebrates, probably, enabling larger embryos and
faster growth rates.
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